Syn-Tech Chem & Pharm Co (ROCO:1777) ROCE %: 17.63% (As of Dec. 2025)


ROCO:1777 Syn-Tech Chem & Pharm Co Ltd ROCO:1777
72 GF Score
Price NT$71.70
GF Value NT$106.23
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Syn-Tech Chem & Pharm Co ROCE %?

Syn-Tech Chem & Pharm Co ROCO:1777 +0.14% 72 ROCE % is 17.63% as of Dec. 2025. GuruFocus rates ROCO:1777 with a GF Score™ of 72/100 and a GF Value™ of NT$106.23 (Significantly Undervalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Syn-Tech Chem & Pharm Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 17.63%.

Syn-Tech Chem & Pharm Co  (ROCO:1777) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Syn-Tech Chem & Pharm Co ROCE % Related Terms

Syn-Tech Chem & Pharm Co ROCE % Historical Data

* Premium members only.

The historical data trend for Syn-Tech Chem & Pharm Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syn-Tech Chem & Pharm Co ROCE % Chart

Syn-Tech Chem & Pharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.07 16.68 13.68 19.51 12.67

Syn-Tech Chem & Pharm Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.14 14.88 4.36 15.52 17.63
ROCO:1777
72GF Score
Syn-Tech Chem & Pharm Co Ltd ROCO:1777
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syn-Tech Chem & Pharm Co ROCE % Calculation

Syn-Tech Chem & Pharm Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=334.923/( ( (2851.865 - 219.471) + (2959.852 - 304.49) )/ 2 )
=334.923/( (2632.394+2655.362)/ 2 )
=334.923/2643.878
=12.67 %

Syn-Tech Chem & Pharm Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=460.092/( ( (2700.439 - 137.342) + (2959.852 - 304.49) )/ 2 )
=460.092/( ( 2563.097 + 2655.362 )/ 2 )
=460.092/2609.2295
=17.63 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 17.63% mean?
Syn-Tech Chem & Pharm Co (ROCO:1777) has a ROCE % of 17.63% as of Dec. 2025.
Is Syn-Tech Chem & Pharm Co's ROCE % too high?
Syn-Tech Chem & Pharm Co's current ROCE % is 17.63%. Overall, Syn-Tech Chem & Pharm Co has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Syn-Tech Chem & Pharm Co's ROCE % compare to VRTX and REGN?
Syn-Tech Chem & Pharm Co's ROCE % of 17.63% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Syn-Tech Chem & Pharm Co's current ROCE % is 17.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syn-Tech Chem & Pharm Co stock overvalued right now?
Based on GuruFocus' analysis, Syn-Tech Chem & Pharm Co (ROCO:1777) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$106.23, compared to a current price of NT$71.70 — trading 32.5% below its estimated fair value. The current ROCE % is 17.63%. Syn-Tech Chem & Pharm Co's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Syn-Tech Chem & Pharm Co (ROCO:1777), the current ROCE % is 17.63% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Syn-Tech Chem & Pharm Co (ROCO:1777) Overvalued in 2026?

Based on GuruFocus' analysis, Syn-Tech Chem & Pharm Co stock appears to be undervalued. The current stock price of NT$71.70 is trading 32.5% below its estimated GF Value™ of NT$106.23. GuruFocus considers Syn-Tech Chem & Pharm Co to be Significantly Undervalued.

Key valuation signals for ROCO:1777:

  • ROCE %: 17.63%
  • GF Value™: NT$106.23 vs. price of NT$71.70 (32.5% below fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the ROCO:1777 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Syn-Tech Chem & Pharm Co Business Description

Address No. 168, Kai Yuan Road, Xinying District, Tainan City, TWN, 73055
Syn-Tech Chem & Pharm Co Ltd is engaged in the manufacture and sale of western medicines, veterinary drugs, food additives, cosmetics, and related businesses. It manufactures and sells Active Pharmaceutical Ingredients for domestic and foreign pharmaceutical companies and trade agents. Its products include Alfuzosin HCl, Atomoxetine HCl, Chlorzoxazone, Chlormezanone, Cloperastine HCl, Crotamiton, Diclofenac Epolamine, and others. It generates the majority of its revenue from Asia excluding Taiwan.
72GF Score

Get the complete analysis for ROCO:1777

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$71.70
Price
NT$106.23
GF Value